Vorapaxar(free base)
编号: 16070916
Cas号: 618385-01-6
纯度: 98% by HPLC
Vorapaxar, also known as SCH 530348, is a thrombin receptor (protease-activated receptor, PAR-1) antagonist based on the natural product himbacine. Discovered by Schering-Plough and currently being developed by Merck & Co., it is an experimental pharmaceutical treatment for acute coronary syndrome chest pain caused by coronary artery disease. On May 05, 2014, vorapaxar obtained FDA approval.
仅供研究使用。 我们不向患者出售。
化学信息
| 名称 | Vorapaxar(free base) |
|---|---|
| Iupac 化学名称 | Ethyl N-[(3R,3aS,4S,4aR,7R,8aR,9aR)-4-[(E)-2-[5-(3-fluorophenyl)-2-pyridyl]vinyl]-3-methyl-1-oxo-3a,4,4a,5,6,7,8,8a,9,9a-decahydro-3H-benzo[f]isobenzofuran-7-yl]carbamate |
| 同义词 | SCH530348;SCH 530348, |
| 英文同义词 | SCH530348;SCH 530348, |
| 分子式 | C29H35FN2O8S |
| 分子量 | 590.6634 |
| Smile | FC=1C=C(C=CC1)C=1C=CC(=NC1)/C=C/[C@H]1[C@H]2[C@H](C[C@H]3C(O[C@@H]([C@@H]13)C)=O)C[C@@H](CC2)NC(OCC)=O |
| InChiKey | ZBGXUVOIWDMMJE-QHNZEKIYSA-N |
| InChi | InChI=1S/C29H33FN2O4/c1-3-35-29(34)32-23-10-11-24-20(14-23)15-26-27(17(2)36-28(26)33)25(24)12-9-22-8-7-19(16-31-22)18-5-4-6-21(30)13-18/h4-9,12-13,16-17,20,23-27H,3,10-11,14-15H2,1-2H3,(H,32,34)/b12-9+/t17-,20+,23-,24-,25+,26-,27+/m1/s1 |
| Cas号 | 618385-01-6 |
| 相关CAS号 |
订购信息
| 包装 | 价格 | 库存 | 纯度 | 备货期 |
|---|---|---|---|---|
| 大货 | 询价 | 询价 | 询价 |
-cas-618385-01-6.png)